Phoenix Molecular Designs Successfully Completes Patient Enrollment in Phase 1/1b Clinical Trial of PMD-026
SAN DIEGO and VANCOUVER, BC, Feb. 9, 2022 /PRNewswire/ - Phoenix Molecular Designs (PhoenixMD), a clinical stage biopharmaceutical company dedicat...
Source: businessinsider.com